NFKB1 and pancreatic neoplasm: To the best of our knowledge, the present study provides the first evidence that DDTC inhibits NF-κB activity, decreases the expression of Bcl-2 and enhances the inhibitory effects of TPA on pancreatic cancer cell growth in vitro and in vivo.